Breaking News Instant updates and real-time market news.

TROV

Trovagene

$3.10

0.1 (3.33%)

08:05
11/28/16
11/28
08:05
11/28/16
08:05

Trovagene says PCM technology yields significantly greater detection sensitivity

Trovagene announced that the use of their Precision Cancer Monitoring technology for both urine and plasma EGFR mutation testing yielded significantly greater detection sensitivity than tissue testing alone. Data will be presented at the 17th World Conference on Lung Cancer, December 4-7 in Vienna, Austria. Trovagene's abstract entitled, A Highly Sensitive Next Generation Sequencing Platform for Detection of NSCLC EGFR T790M in Urine and Plasma, was selected for an oral presentation. This presentation will include data showing a 95% overall detection rate of EGFR T790M by combined urine and plasma versus 83% detection by tissue testing. Additionally, the detection rate in intrathoracic lung cancer disease, in the absence of distant metastases, was an unprecedented 93%. This data further validates the high sensitivity of Trovagene's, Trovera urine and blood liquid biopsy test to identify the EGFR T790M resistance mutation in patients with late-stage non-small cell lung cancer progressing on 1st or 2nd generation TKIs. Two additional abstracts, one a case series, focus on recent work demonstrating that EGFR ctDNA can serve as an early indicator of therapeutic response, providing valuable information particularly in the setting of late-stage patients treated with experimental therapeutics or in patients progressing on therapy. The dynamic changes in ctDNA EGFR systemic load observed in this case series is consistent with previous findings. A fourth poster presentation will feature cost of care analysis data demonstrating the value of a urine testing strategy as a dominant care pathway compared to a tissue testing strategy by saving costs and improving progression-free and overall survival for patients with non-small cell lung cancer.

  • 29

    Nov

TROV Trovagene
$3.10

0.1 (3.33%)

07/07/16
PIPR
07/07/16
NO CHANGE
PIPR
New FDA recommendation positive for lab companies, says Piper Jaffray
Piper Jaffray analyst William Quirk says that the FDA has issued draft guidance to streamline its approval process for next-generation sequencing, or NGS, germline tests, which could be a substitute for a Premarket Notification or 510k. The analyst believes streamlined regulatory approaches for NGS tests are a positive for labs with NGS laboratory-developed tests such as CareDx (CDNA), Quest Diagnostics (DGX), Genomic Health (GHDX), LabCorp (LH), Myriad Genetics (MYGN), Natera (NTRA), Oxford Immunotec (OXFD), Sequenom (SQNM), Trovagene (TROV), and Veracyte (VCYT).
08/08/16
CANT
08/08/16
UPGRADE
CANT
Buy
Trovagene upgraded to Buy from Hold at Cantor
08/08/16
CANT
08/08/16
UPGRADE
Target $7
CANT
Buy
Trovagene upgraded to Buy with $7 target at Cantor
Cantor Fitzgerald analyst Bryan Brokmeier upgraded Trovagene to Buy from Hold citing the company's accelerating clinical business. In Q2, the company increased the number of physicians on the platform to approximately 700 physicians from 550 in Q1, Brokmeier tells investors in a research note. He points out that Trovagene is also targeting new biopharma collaborations. The analyst raised his price target for the shares to $7 from $5.
09/30/16
CANT
09/30/16
NO CHANGE
CANT
Trovagene outlook has improved, says Cantor
After meeting with Trovagene's management, Cantor analyst Bryan Brokmeier is more upbeat on the stock. He says that the company's new strategy :"significantly reduces" its cash needs, provides it with multiple potential positive catalysts and reduces its competition. The analyst keeps an $8 price target and Buy rating on the shares.

TODAY'S FREE FLY STORIES

OKTA

Okta

$29.80

0.62 (2.12%)

15:02
01/23/18
01/23
15:02
01/23/18
15:02
Conference/Events
Okta has a conference call hosted by William Blair »

William Blair will host a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

  • 26

    Feb

AET

Aetna

$189.32

-0.02 (-0.01%)

15:02
01/23/18
01/23
15:02
01/23/18
15:02
Hot Stocks
Aetna to pay $1.15M in settlement with NY AG over privacy breach »

New York Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIBK

First Interstate

$42.80

0.2 (0.47%)

15:01
01/23/18
01/23
15:01
01/23/18
15:01
Hot Stocks
First Interstate names Renee Newman chief banking officer »

First Interstate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSC

Norfolk Southern

$150.73

-0.74 (-0.49%)

14:57
01/23/18
01/23
14:57
01/23/18
14:57
Hot Stocks
Norfolk Southern increases quarterly dividend 18% to 72c per share »

Norfolk Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FBM

Foundation Building Materials

$15.36

-0.14 (-0.90%)

14:52
01/23/18
01/23
14:52
01/23/18
14:52
Conference/Events
Foundation Building Materials has a conference call hosted by Willian Blair »

William Blair will host a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

MAT

Mattel

$16.09

-0.05 (-0.31%)

14:50
01/23/18
01/23
14:50
01/23/18
14:50
Options
Timely call buying in Mattel »

Timely call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 20

    Feb

HMNY

Helios and Matheson

$8.27

0.19 (2.35%)

14:45
01/23/18
01/23
14:45
01/23/18
14:45
Options
Helios and Matheson call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$16.09

-0.05 (-0.31%)

, HAS

Hasbro

$90.86

-1.7 (-1.84%)

14:42
01/23/18
01/23
14:42
01/23/18
14:42
Periodicals
Mattel gives CNN no comment on stock jump »

Paul La Monica of CNN…

MAT

Mattel

$16.09

-0.05 (-0.31%)

HAS

Hasbro

$90.86

-1.7 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 20

    Feb

  • 20

    Feb

AAPL

Apple

$177.00

-1.46 (-0.82%)

14:41
01/23/18
01/23
14:41
01/23/18
14:41
Recommendations
Apple analyst commentary  »

JPMorgan sees more signs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

GE

General Electric

$16.96

0.785 (4.85%)

14:30
01/23/18
01/23
14:30
01/23/18
14:30
Options
Heavy trading in GE as shares rally ahead of earnings »

Heavy trading in GE as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SNE

Sony

$51.00

0.2 (0.39%)

, AAPL

Apple

$177.00

-1.46 (-0.82%)

14:25
01/23/18
01/23
14:25
01/23/18
14:25
Downgrade
Sony, Apple rating change  »

Sony downgraded to…

SNE

Sony

$51.00

0.2 (0.39%)

AAPL

Apple

$177.00

-1.46 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

EXAS

Exact Sciences

$48.49

0.67 (1.40%)

14:25
01/23/18
01/23
14:25
01/23/18
14:25
Options
EXACT Sciences call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MAT

Mattel

$16.09

-0.05 (-0.31%)

, HAS

Hasbro

$90.86

-1.7 (-1.84%)

14:22
01/23/18
01/23
14:22
01/23/18
14:22
Hot Stocks
Breaking Hot Stocks news story on Mattel, Hasbro »

Mattel, Hasbro rally to…

MAT

Mattel

$16.09

-0.05 (-0.31%)

HAS

Hasbro

$90.86

-1.7 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 20

    Feb

  • 20

    Feb

FB

Facebook

$185.37

4.08 (2.25%)

14:18
01/23/18
01/23
14:18
01/23/18
14:18
Hot Stocks
Facebook CMO leaving to advise other companies, help Democratic Party »

In a status update, Gary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

$NSD

NASDAQ Market Internals

14:17
01/23/18
01/23
14:17
01/23/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/23/18
01/23
14:16
01/23/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$89.35

-1.29 (-1.42%)

14:15
01/23/18
01/23
14:15
01/23/18
14:15
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

TWTR

Twitter

$22.84

-0.5 (-2.14%)

14:13
01/23/18
01/23
14:13
01/23/18
14:13
Recommendations
Twitter analyst commentary  »

Noto departure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

AAPL

Apple

$177.00

-1.46 (-0.82%)

14:10
01/23/18
01/23
14:10
01/23/18
14:10
Periodicals
KGI's Kuo says Apple's next iPhone to have no 3D touch, MacRumors reports »

Apple may launch a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SNE

Sony

$51.80

0.995 (1.96%)

14:10
01/23/18
01/23
14:10
01/23/18
14:10
Downgrade
Sony rating change  »

Sony downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

14:10
01/23/18
01/23
14:10
01/23/18
14:10
General news
U.S. equities cooled off from record highs »

U.S. equities cooled off…

BTC

Bitcoin

, BITCOIN

Bitcoin

14:09
01/23/18
01/23
14:09
01/23/18
14:09
Hot Stocks
Stripe says ending Bitcoin support »

Tom Karlo, Stripe's…

BTC

Bitcoin

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REG

Regency Centers

$64.46

0.15 (0.23%)

14:08
01/23/18
01/23
14:08
01/23/18
14:08
Hot Stocks
Regency Centers acquires Whole Foods Market-anchored center in New Jersey »

Regency Centers …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

TEVA

Teva

$20.80

-0.22 (-1.05%)

, JNJ

Johnson & Johnson

$142.63

-5.51 (-3.72%)

14:06
01/23/18
01/23
14:06
01/23/18
14:06
Hot Stocks
NYC sues drug manufacturers, distributors over opioid epidemic »

New York City Mayor Bill…

TEVA

Teva

$20.80

-0.22 (-1.05%)

JNJ

Johnson & Johnson

$142.63

-5.51 (-3.72%)

ENDP

Endo

$7.31

0.2 (2.81%)

MCK

McKesson

$171.56

-1.405 (-0.81%)

CAH

Cardinal Health

$73.46

-0.05 (-0.07%)

ABC

AmerisourceBergen

$102.96

0.3 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 01

    Feb

  • 06

    Feb

  • 08

    Feb

  • 16

    Feb

  • 08

    Mar

SHLD

Sears

$3.45

-0.18 (-4.96%)

14:05
01/23/18
01/23
14:05
01/23/18
14:05
Hot Stocks
Fitch downgrades Sears Holdings to 'C' on distressed debt exchange announcement »

Fitch Ratings has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.